Salmonella Detection Culture Medium Using Para-Aminobenzoic Acid

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for detecting Salmonella bacteria in complex samples face challenges in achieving both sensitivity and selectivity, particularly due to the competition of costly substrates like alafosfalin, which are expensive and not conducive to the growth of Salmonella genus bacteria, leading to false-negative results and high costs.

Innovation Solution

A culture medium containing para-aminobenzoic acid as a selective agent, which inhibits the growth of gram-negative bacteria, thereby promoting the detection of Salmonella genus bacteria, combined with chromogenic or fluorogenic substrates and bile salts to enhance selectivity and sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If alafosfalin is used as a selective agent, then selectivity against gram-negative bacteria is improved, but cost increases and Salmonella growth is inhibited leading to false-negative results

Engineering Contradiction:
ImproveselectivityVSAvoidcost
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent replaces the expensive alafosfalin substrate with a much cheaper selective agent system. The new medium uses affordable components while maintaining selective inhibition of gram-negative bacteria, eliminating the need for costly suicide substrates that compromise Salmonella growth.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the chemical parameters of the selective agent from alafosfalin (a phosphonic acid derivative) to a different chemical system that achieves selective inhibition without the harmful side effects. This parameter change allows Gram-negative bacteria to be inhibited while Salmonella can still grow and be detected.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If alafosfalin is used as a selective agent, then selectivity against gram-negative bacteria is improved, but Salmonella detection sensitivity deteriorates due to growth inhibition

Engineering Contradiction:
ImproveselectivityVSAvoidsensitivity
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

By replacing alafosfalin with a cheaper alternative selective agent, the patent eliminates the growth inhibition problem that caused false-negative results. The new selective system allows Salmonella to grow normally while still preventing gram-negative bacteria growth, thereby restoring sensitivity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent converts the harmful effect of alafosfalin (inhibiting Salmonella growth) into a beneficial outcome by using a different selective mechanism that specifically targets gram-negative bacteria without affecting Salmonella. This allows the medium to be both selective and sensitive.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Difficulty of detecting and measuring

If chromogenic substrates are used to differentiate Salmonella, then detection capability is improved, but false-negative results increase due to masking by non-target microorganisms

Engineering Contradiction:
Improvedetection capabilityVSAvoidfalse-negative rate
Core Design Contradiction:
Difficulty of detecting and measuringVSReliability

Solution Approach 1:

The patent applies preliminary selective inhibition of gram-negative bacteria before the chromogenic differentiation step. By pre-inhibiting non-target microorganisms using the new selective agent, the medium prevents them from growing and masking Salmonella colonies, ensuring that chromogenic signals are not obscured.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent segments the detection process into two distinct functions: (1) selective inhibition of gram-negative bacteria using the new selective agent, and (2) chromogenic differentiation of Salmonella. This segmentation ensures that the two functions do not interfere with each other, maintaining both detection capability and reliability.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of para-aminobenzoic acid in the culture medium effectively inhibits non-target gram-negative bacteria, allowing for the specific detection of Salmonella bacteria with improved sensitivity and selectivity, reducing false-negative results and costs compared to previous methods.

Implementation Method 1

para-aminobenzoic acid as a selective agent, which inhibits the growth of gram-negative bacteria, thereby promoting the detection of Salmonella genus bacteria

Methodology Applied
Scientific EffectAntimicrobial inhibition:

Implementation Method 2

they contain enzyme substrates specifically cleaved or digested by the target bacteria, such that a coloured reaction product is generated

Methodology Applied
Scientific EffectEnzymatic hydrolysis: Hydrolysis

Implementation Method 3

enzyme substrates specifically cleaved or digested by the target bacteria

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 4

bile salts are present in the medium to selectively inhibit the gram-positive species

Methodology Applied
Scientific EffectSelective antimicrobial inhibition:

Data Source

PatentUS10233477B2Culture medium for microorganisms including para-aminobenzoic acid as a selective agent
Publication Date: 2019.03.19 BIOMERIEUX SA

AI summary

The field of the invention is the analysis of target microorganisms in a complex sample. The present invention more particularly relates to a culture medium for the detection of at least one target microorganism including: at least one natural or synthetic fermentation or enzymatic activity substrate, and at least one selective agent, which inhibits non-target microorganisms, constituted by para-amino benzoic acid, one of its derivatives or one of their salts, at a concentration of between 0.05 and 1 g/L.